AMGN
Amgen Inc.
- Operating income, 2025
- $9.1B
- YoY, 2025
- +25.1%
- 5-year CAGR
- −0.1%
- 10-year CAGR
- +0.7%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $9.1B | +25.1% |
| 2024 | $7.3B | −8.1% |
| 2023 | $7.9B | −17.4% |
| 2022 | $9.6B | +25.2% |
| 2021 | $7.6B | −16.4% |
| 2020 | $9.1B | −5.5% |
| 2019 | $9.7B | −5.7% |
| 2018 | $10.3B | +2.9% |
| 2017 | $10.0B | +1.8% |
| 2016 | $9.8B | +15.6% |
| 2015 | $8.5B | +36.8% |
| 2014 | $6.2B | +5.5% |
| 2013 | $5.9B | +5.2% |
| 2012 | $5.6B | +29.3% |
| 2011 | $4.3B | −22.2% |
| 2010 | $5.5B | +0.7% |
| 2009 | $5.5B | +5.6% |
| 2008 | $5.2B | +31.0% |
| 2007 | $4.0B | — |